Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.74
-0.26 (-2.60%)
At close: Oct 7, 2025, 4:00 PM EDT
9.77
+0.03 (0.31%)
After-hours: Oct 7, 2025, 4:10 PM EDT

Cartesian Therapeutics Revenue

Cartesian Therapeutics had revenue of $298.00K in the quarter ending June 30, 2025, a decrease of -99.11%. This brings the company's revenue in the last twelve months to $1.03M, down -98.10% year-over-year. In the year 2024, Cartesian Therapeutics had annual revenue of $38.91M with 49.64% growth.

Revenue (ttm)
$1.03M
Revenue Growth
-98.10%
P/S Ratio
234.61
Revenue / Employee
$15,545
Employees
66
Market Cap
253.26M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RNAC News

More News